Position in AZN
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$42,534,041
-$3,391,988 QoQ
Shares Held
224,312
-3.7% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.88%
of 13F equity value
Holder Rank
#168
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Crestwood Advisors Group, LLC holds $223,873,417 across 13 Drug Manufacturers - General names. AZN ranks #3 (19.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
268,723 | $68,247,580 | |
| 2 | LLY |
ELI LILLY & Co
|
44,320 | $53,158,741 | |
| 3 | AZN |
Astrazeneca PLC
This page
|
224,312 | $42,534,041 | |
| 4 | ABBV |
AbbVie Inc.
|
122,966 | $30,943,164 | |
| 5 | MRK |
Merck & Co., Inc.
|
114,219 | $14,677,141 | |
| 6 | AMGN |
Amgen Inc
|
14,249 | $5,159,847 | |
| 7 | PFE |
Pfizer Inc
|
137,811 | $3,318,488 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
20,797 | $2,627,492 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $42,534,041 | 224,312 | Shares | Other | 2026-08-03 | |
| 2026-03-31 | $45,926,029 | 232,867 | Shares | Other | 2026-05-05 | |
| No filing history on record for this holder in this stock. | ||||||